tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
VCEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsVCEL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
17d ago
Vericel: Strong MACI-Driven Performance, Robust Balance Sheet, and Multi-Pronged Growth Catalysts Support Buy Rating and $60 Target
Premium
Ratings
Vericel: Strong MACI-Driven Performance, Robust Balance Sheet, and Multi-Pronged Growth Catalysts Support Buy Rating and $60 Target
2M ago
Vericel: Underappreciated High-Growth MACI Leader with Strengthening Profitability and a Long Runway Justifying Buy Rating
Premium
Ratings
Vericel: Underappreciated High-Growth MACI Leader with Strengthening Profitability and a Long Runway Justifying Buy Rating
2M ago
Vericel’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
PremiumRatingsVericel’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
4M ago
Vericel Corporation Reports Strong Q3 2025 Results
Premium
Company Announcements
Vericel Corporation Reports Strong Q3 2025 Results
4M ago
Vericel Corporation Reports Record Revenue and Growth
Premium
Company Announcements
Vericel Corporation Reports Record Revenue and Growth
4M ago
Vericel price target lowered to $41 from $46 at Truist
PremiumThe FlyVericel price target lowered to $41 from $46 at Truist
5M ago
Vericel’s Promising Growth: Buy Rating Backed by MACI Revenue Surge and Successful MACI Arthro Launch
Premium
Ratings
Vericel’s Promising Growth: Buy Rating Backed by MACI Revenue Surge and Successful MACI Arthro Launch
5M ago
Vericel’s Strategic Growth and Market Expansion Drive Buy Rating
Premium
Ratings
Vericel’s Strategic Growth and Market Expansion Drive Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100